International Journal of Pharmaceutical Compounding

A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of your subscribed issues, individual articles, and purchased archives.

LEARN MORE

Bosentan 6.25-mg/mL Oral Suspension

Author(s): Allen Loyd V Jr

Issue: Nov/Dec 2016 - Volume 20, Number 6
View All Articles in Issue

Page(s): 505

Bosentan 6.25-mg/mL Oral Suspension Page 1

Download in electronic PDF format for $75

Abstract: A formulation for preparing Bosentan 6.25-mg/mL Oral Suspension. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords: Loyd V. Allen, Jr., PhD, RPh, formulation, hazardous medication, pulmonary arterial hypertension, bosentan, exercise capacity

Related Categories: FORMULATIONS, CARDIOLOGY, RESPIRATION/LUNG/BREATHING, HAZARDOUS DRUGS

Printer-Friendly Version

Title/Author (Click for Abstract / Details / Purchase)	Issue/Page View/Buy
Related Articles from IJPC
Bosentan 6.25-mg/mL Oral Suspension Allen Loyd V Jr	Nov/Dec 2016 Pg. 505
Veterinary Transdermal Medications: A to Z Davidson Gigi S	Mar/Apr 2003 Pg. 106-113
Rapid-Dissolve Technology: An Interview With Loyd V. Allen, Jr., PhD, RPh Allen Loyd V Jr	Nov/Dec 2003 Pg. 449-450
Compounding in the Pharmacy Curriculum: Beyond the Basics Hinkle Amanda R, Newton Gail D	May/Jun 2004 Pg. 181-185
Basics of Compounding for Cough Allen Loyd V Jr	Nov/Dec 2004 Pg. 462-465
Treatment of Canine Pulmonary Hypertension: Is Tadalafil an Appropriate Alternative to Sildenafil? Wung Deanna	Jan/Feb 2013 Pg. 24-27
Diverse Challenges in Pediatric Compounding: Treating Pulmonary Hypertension, Uncombable Hair Syndrome, and Acanthamoeba keratitis Muller George, Young Thomas W, Reina Rachel, Caldwell Delmar R	Jan/Feb 2010 Pg. 40-45
Application of Sildenafil for Pulmonary Hypertension in Canines and Foals Davidson Gigi S	Nov/Dec 2006 Pg. 405-408
Carvedilol 3.125-mg, 6.25-mg, 12.5 mg, or 25-mg capsules Allen Loyd V Jr	Mar/Apr 2016 Pg. 145
Amlodipine Besylate 0.5-mg/mL to 10-mg/mL in SuspendIt Oral Suspension Allen Loyd V Jr	Jan/Feb 2021 Pg. 43
Clonidine 0.01-mg/mL in Oral Mix and Oral Mix SF Suspension Allen Loyd V Jr	Jan/Feb 2021 Pg. 44
Nitazoxanide 10-mg/mL Oral Suspension Allen Loyd V Jr	Sep/Oct 2023 Pg. 420
Sorafenib 20-mg/mL in Oil Oral Suspension Allen Loyd V Jr	Sep/Oct 2021 Pg. 420
Metoprolol Tartrate 10 mg/mL in SyrSpend SF pH4 Oral Suspension Allen Loyd V Jr	Nov/Dec 2021 Pg. 503
Pyridoxine Hydrochloride 25 mg/mL in Oral Mix and Oral Mix SF Suspension Allen Loyd V Jr	Nov/Dec 2021 Pg. 505
Propranolol 2 mg/mL and 5 mg/mL in Ora-Blend SF Suspension Allen Loyd V Jr	Mar/Apr 2022 Pg. 148
Metronidazole 50-mg/mL in Oral Mix and Oral Mix SF Suspension Allen Loyd V Jr	Jan/Feb 2021 Pg. 47
Atomoxetine 4-mg/mL Oral Solution/Suspension Allen Loyd V Jr	Jul/Aug 2021 Pg. 321
Dapsone 2-mg/mL in Oral Mix or Oral Mix SF Suspension Allen Loyd V Jr	Sep/Oct 2021 Pg. 415
Dexamethasone 1-mg/mL in Oral Mix or Oral Mix SF Suspension Allen Loyd V Jr	Sep/Oct 2021 Pg. 416
Return to Top